Insulin × glycemic control

TrialCardiovascular diabetology2011

Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of pioglitazone, metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: the PIOCOMB study.

Markolf Hanefeld et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 121 people · 2011

No range given

Reported higher glycemic control, no range given

+2.50units

As reported

difference 2.5 units, no interval

One number in the abstract

the abstract, start to end

in C (p = 0.0004), but was increased by 2.5 units (p = 0.1539) in A at

← favours treatmentfavours comparator →
could be chance
No interval given · direction only, strength unknown
Glycemic control
2.5
InsulinGlycemic control
1 / 3

16 papers cite it

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 21756323